dipyridamole has been researched along with Cardiomyopathy, Dilated in 30 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 7.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "We studied 22 patients with IDC and 22 control subjects using PET with nitrogen-13 ammonia to measure myocardial blood flow (MBF) at rest and during dipyridamole-induced hyperemia." | 3.70 | Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. ( Blanksma, PK; Crijns, HJ; Siebelink, HM; Vaalburg, WM; van den Heuvel, AF; van der Wall, EE; van Gilst, WH; van Veldhuisen, DJ, 2000) |
| "Absolute regional MBF (milliliters per minute per gram) was measured by positron emission tomography and 13N-ammonia in resting conditions, during pacing-induced tachycardia, and after dipyridamole infusion (0." | 3.69 | Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. ( Gallopin, M; Giorgetti, A; Lunardi, M; Michelassi, C; Neglia, D; Parodi, O; Pelosi, G; Pratali, L; Salvadori, P; Sambuceti, G, 1995) |
| "A method for quantitative determination of the percentage of left ventricular myocardial 201Tl isotope uptake at rest and during dipyridamole test was first used in patients with dilated cardiomyopathy and coronary heart disease complicated by circulatory insufficiency or chronic myocarditis." | 3.68 | [The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test]. ( Belenkov, IuN; Naumov, VG; Ostroumov, EN; Saidova, MA; Sergienko, VB, 1992) |
| "Patients with non ischemic-dilated cardiomyopathy (DCM) are characterized by an activation of the adenosinergic system and reduced coronary flow reserve (CFR) evaluated by transthoracic Doppler echocardiography during vasodilator adenosinergic stress (dipyridamole administration)." | 2.76 | Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy. ( Andreassi, MG; Borghini, A; Capecchi, PL; Foffa, I; Laghi Pasini, F; Picano, E; Pompella, G; Sicari, R, 2011) |
| "atheromatous coronary disease, dilated cardiomyopathy, scleroderma, sarcoidosis) and in patients who had undergone heart transplantation." | 2.37 | [Coronary reserve: a dynamic evaluation of coronary circulation]. ( Foult, JM; Nitenberg, A, 1987) |
| "In Idiopathic Dilated Cardiomyopathy (IDC) an imbalance between myocardial oxygen consumption and supply has been postulated." | 1.36 | Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. ( Dierckx, RA; Lubbers, DD; Slart, RH; Tio, RA; van der Vleuten, PA; van Veldhuisen, DJ; Willems, TP, 2010) |
| "In a Cox model, mitral insufficiency (hazard ratio [HR] 1." | 1.34 | The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. ( Galderisi, M; Gherardi, S; Picano, E; Rigo, F; Sicari, R, 2007) |
| "Twenty-six patients with dilated cardiomyopathy and angiographically normal coronary arteries, 12 of whom gave a history of anginal chest pain, underwent noninvasive and invasive hemodynamic study." | 1.27 | Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. ( Cannon, RO; Cunnion, RE; Epstein, SE; Palmeri, ST; Parrillo, JE; Schenke, WH; Tucker, EE, 1987) |
| "The dipyridamole test was performed during diagnostic coronaro-ventriculography in 7 patients showing no angiographic signs of coronary atherosclerosis (group 1) and 15 patients with a 75% stenosis in one or more coronary arteries (group 2)." | 1.27 | [Changes in segmental and general left ventricular myocardial contractility and intracardiac hemodynamics in the dipyridamole test of patients with ischemic heart disease (data of roentgenocontrast ventriculography)]. ( Koshumbaeva, KM; Samko, AN; Savchenko, AP; Sidorenko, BA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (33.33) | 18.7374 |
| 1990's | 7 (23.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 5 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwartzmann, PV | 1 |
| Carvalho, EE | 1 |
| de Figueiredo, AB | 1 |
| Marin-Neto, JA | 1 |
| Simões, MV | 1 |
| Ciampi, Q | 1 |
| Cortigiani, L | 2 |
| Pratali, L | 4 |
| Rigo, F | 3 |
| Villari, B | 1 |
| Picano, E | 7 |
| Sicari, R | 4 |
| Giannessi, D | 1 |
| Caselli, C | 1 |
| Del Ry, S | 1 |
| Maltinti, M | 1 |
| Pardini, S | 1 |
| Turchi, S | 1 |
| Cabiati, M | 1 |
| Sampietro, T | 1 |
| Abraham, N | 1 |
| L'abbate, A | 1 |
| Neglia, D | 2 |
| Slart, RH | 1 |
| Tio, RA | 1 |
| van der Vleuten, PA | 1 |
| Willems, TP | 1 |
| Lubbers, DD | 1 |
| Dierckx, RA | 1 |
| van Veldhuisen, DJ | 2 |
| Andreassi, MG | 1 |
| Laghi Pasini, F | 1 |
| Capecchi, PL | 2 |
| Pompella, G | 1 |
| Foffa, I | 1 |
| Borghini, A | 1 |
| Laghi-Pasini, F | 1 |
| Guideri, F | 1 |
| Petersen, C | 1 |
| Lazzerini, PE | 1 |
| Stolen, KQ | 1 |
| Kemppainen, J | 1 |
| Kalliokoski, KK | 1 |
| Karanko, H | 1 |
| Toikka, J | 1 |
| Janatuinen, T | 1 |
| Raitakari, OT | 1 |
| Airaksinen, KE | 1 |
| Nuutila, P | 1 |
| Knuuti, J | 1 |
| Watzinger, N | 1 |
| Lund, GK | 1 |
| Saeed, M | 1 |
| Reddy, GP | 1 |
| Araoz, PA | 1 |
| Yang, M | 1 |
| Schwartz, AB | 1 |
| Bedigian, M | 1 |
| Higgins, CB | 1 |
| Otasevic, P | 2 |
| Gherardi, S | 2 |
| Neskovic, A | 2 |
| Chinnaiyan, KM | 1 |
| Trivax, J | 1 |
| Franklin, BA | 1 |
| Williamson, B | 1 |
| Kahn, JK | 1 |
| Galderisi, M | 1 |
| Molinaro, S | 1 |
| Grec, V | 1 |
| Grbic, M | 1 |
| Sigwart, U | 1 |
| Parodi, O | 1 |
| Gallopin, M | 1 |
| Sambuceti, G | 1 |
| Giorgetti, A | 1 |
| Salvadori, P | 1 |
| Michelassi, C | 1 |
| Lunardi, M | 1 |
| Pelosi, G | 1 |
| Merlet, P | 1 |
| Mazoyer, B | 1 |
| Hittinger, L | 1 |
| Valette, H | 1 |
| Saal, JP | 1 |
| Bendriem, B | 1 |
| Crozatier, B | 1 |
| Castaigne, A | 1 |
| Syrota, A | 1 |
| Randé, JL | 1 |
| Weismüller, S | 1 |
| Czernin, J | 1 |
| Sun, KT | 1 |
| Fung, C | 1 |
| Phelps, ME | 1 |
| Schelbert, HR | 1 |
| Kalsi, KK | 1 |
| Smolenski, RT | 1 |
| Pritchard, RD | 1 |
| Khaghani, A | 1 |
| Seymour, AM | 1 |
| Yacoub, MH | 1 |
| Baroni, M | 1 |
| Palmieri, C | 1 |
| Boni, A | 1 |
| Ravani, M | 1 |
| Biagini, A | 1 |
| Nannini, E | 1 |
| van den Heuvel, AF | 1 |
| van der Wall, EE | 1 |
| Blanksma, PK | 1 |
| Siebelink, HM | 1 |
| Vaalburg, WM | 1 |
| van Gilst, WH | 1 |
| Crijns, HJ | 1 |
| Saidova, MA | 1 |
| Ostroumov, EN | 1 |
| Naumov, VG | 1 |
| Sergienko, VB | 1 |
| Belenkov, IuN | 1 |
| Chikamori, T | 1 |
| Doi, YL | 1 |
| Yonezawa, Y | 1 |
| Yamada, M | 2 |
| Seo, H | 1 |
| Ozawa, T | 2 |
| Yabe, T | 1 |
| Doi, Y | 1 |
| Yonesawa, Y | 1 |
| Takada, J | 1 |
| Odawara, H | 1 |
| Cannon, RO | 2 |
| Nitenberg, A | 2 |
| Foult, JM | 2 |
| Shiotani, H | 3 |
| Yamabe, H | 1 |
| Fukuzaki, H | 3 |
| Mori, T | 1 |
| Suda, K | 1 |
| Ohnishi, M | 1 |
| Kanoh, Y | 2 |
| Yokota, Y | 2 |
| Fujitani, K | 1 |
| Maeda, K | 2 |
| Cunnion, RE | 1 |
| Parrillo, JE | 1 |
| Palmeri, ST | 1 |
| Tucker, EE | 1 |
| Schenke, WH | 1 |
| Epstein, SE | 1 |
| Savchenko, AP | 1 |
| Koshumbaeva, KM | 1 |
| Sidorenko, BA | 1 |
| Samko, AN | 1 |
| Ohmori, Y | 1 |
| Blanchet, F | 1 |
| Zouioueche, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Quantification of Myocardial Blood Flow by Positron Emission Tomography in Healthy Volunteers[NCT03895554] | 20 participants (Anticipated) | Observational | 2019-04-01 | Not yet recruiting | |||
| Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)[NCT04343209] | 2,500 participants (Anticipated) | Observational | 2020-09-14 | Recruiting | |||
| Quantification of Myocardial Blood Flow by 3D Positron Emission Tomography With High and Low Rate Rb82 Infusion Profiles[NCT05286593] | Phase 4 | 98 participants (Actual) | Interventional | 2021-12-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dipyridamole and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Coronary flow reserve in patients with chest pain, angiographically normal coronary arteries and normal left ventricle, dilated cardiomyopathy, and hypertrophic cardiomyopathy.
Topics: Angina Pectoris; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Coronary Angiography; Corona | 1989 |
[Coronary reserve: a dynamic evaluation of coronary circulation].
Topics: Cardiomyopathy, Dilated; Coronary Circulation; Coronary Disease; Dipyridamole; Heart Diseases; Heart | 1987 |
1 trial available for dipyridamole and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Adenosine A2(A) receptor gene polymorphism (1976C>T) affects coronary flow reserve response during vasodilator stress testing in patients with non ischemic-dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Echocardiography, Doppler; | 2011 |
27 other studies available for dipyridamole and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
The presence of contractile reserve predicts the left ventricular systolic function improvement after prolonged oral dipyridamole use in patients with non-ischemic dilated cardiomyopathy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiomyopathy, Dilated; Coronary Angiography; Dipyri | 2014 |
Left Bundle Branch Block Negatively Affects Coronary Flow Velocity Reserve and Myocardial Contractile Reserve in Nonischemic Dilated Cardiomyopathy.
Topics: Blood Flow Velocity; Bundle-Branch Block; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Ang | 2016 |
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.
Topics: Adiponectin; Ammonia; Body Mass Index; Cardiomyopathy, Dilated; Cholesterol, HDL; Cohort Studies; Co | 2011 |
Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Female; Fl | 2010 |
Blunted increase in plasma adenosine levels following dipyridamole stress in dilated cardiomyopathy patients.
Topics: Adenosine; Aged; Cardiomyopathy, Dilated; Case-Control Studies; Dipyridamole; Echocardiography, Stre | 2003 |
Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy.
Topics: Brachial Artery; Cardiomyopathy, Dilated; Case-Control Studies; Coronary Circulation; Dipyridamole; | 2004 |
Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Female; Heart Failure; Hum | 2005 |
The additive prognostic value of restrictive pattern and dipyridamole-induced contractile reserve in idiopathic dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Dipyridamole; Echocardiography, Stress; Female; Humans; Male; Middle | 2005 |
Stress testing in patients with implantable cardioverter-defibrillators: a preliminary report.
Topics: Adrenergic beta-Agonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathy, Dilated; Defib | 2007 |
The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy.
Topics: Blood Flow Velocity; Bundle-Branch Block; Cardiac Output, Low; Cardiomyopathy, Dilated; Coronary Ang | 2007 |
Prognostic value of pharmacologic stress echocardiography in patients with idiopathic dilated cardiomyopathy: a prospective, head-to-head comparison between dipyridamole and dobutamine test.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dipyridamole; Dobutamine; Echocardiography, Stress; Fem | 2007 |
[Congestive cardiomyopathy: value of short and long-term vasodilator treatment and prognosis].
Topics: Adult; Aged; Blood Pressure; Cardiomyopathy, Dilated; Dipyridamole; Female; Heart Rate; Humans; Isos | 1983 |
Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography.
Topics: Adult; Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circ | 1995 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels | 1993 |
Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; Heart; | 1996 |
Effects of dipyridamole and adenine/ribose on ATP concentration and adenosine production in cardiac myocytes.
Topics: Adenine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Cardiomyopathy, Dilated; Cardiomyop | 1998 |
Acute hemodynamic effects of endogenous adenosine in patients with chronic heart failure.
Topics: Adenosine; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Dipyridamole; Female; | 1998 |
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Energy Metabolism; Female; | 2000 |
[The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test].
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Dilated; Chronic Disease; Dipyridamole; Electrocardiography | 1992 |
Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Chi-Square Distribution; Coronary Disease; Diagnosis, Differen | 1992 |
[Assessment of prognosis of patients with ventricular tachycardia: role of the underlying heart disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardio | 1989 |
The clinical and prognostic significance of dipyridamole Tl-201 emission computed tomography in patients with dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Dipyridamole; Echocardiography; Female; Humans; Male; Middle Aged; Pr | 1987 |
[Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
Topics: Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dipyrid | 1987 |
Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain.
Topics: Adult; Angina Pectoris; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circulation; D | 1987 |
[Changes in segmental and general left ventricular myocardial contractility and intracardiac hemodynamics in the dipyridamole test of patients with ischemic heart disease (data of roentgenocontrast ventriculography)].
Topics: Adult; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Disease; Dipyridamole; Female; Heart | 1986 |
[201T1 computed tomography using dipyridamole for assessing dilated cardiomyopathy].
Topics: Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Female; Humans; Male; Middle Aged; Myoc | 1985 |
Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Dilated; Corona | 1985 |